SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (790)7/16/1999 6:18:00 PM
From: scaram(o)ucheRead Replies (1) of 4974
 
[off topic]

go, go, go Vioxx!......

biz.yahoo.com

Anybody know if Pfizer has rights to second generation molecules from Searle?

Anybody heard of any further toxicity reports for Celebra or Celebrex or whatever it's called? I get these names confused. Seems like it would also happen to pharmacists..... handwriting errors, if not outright confusion. I think that Searle and Pfizer should be forced to change the name, and open to huge lawsuits if they ignore this sort of plea and patients suffer.

Go Uprima!

Go IC-351!

Any more Trovan news or other reports of toxicity ass'd with Pfizer products?

Toxicity ass'd with Pfizer products?

Toxicity ass'd with Pfizer products?

Toxicity ass'd with Pfizer products?

Toxicity ass'd with Pfizer products?

Toxicity ass'd with Pfizer products?

Toxicity ass'd with Pfizer products?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext